TITLE

Metastatic Processes

AUTHOR(S)
Cobb, Leon M.
PUB. DATE
May 1974
SOURCE
British Medical Journal;5/4/1974, Vol. 2 Issue 5913, p286
SOURCE TYPE
Review
DOC. TYPE
Book Review
ABSTRACT
No abstract available.
ACCESSION #
64110343

 

Related Articles

  • Search for genes that suppress cancer metastasis. Fidler, Isaiah J.; Radinsky, Robert // JNCI: Journal of the National Cancer Institute;12/4/96, Vol. 88 Issue 23, p1700 

    Editorial. Addresses the importance of the study on the search for genes that suppress cancer metastasis. Pathogenesis of cancer metastasis; Recognition of the heterogeneity of neoplasms for metastatic properties; Mechanisms for genetic regulation of the metastatic processes.

  • Monoclonal antibody binds to metastases in PCa trial. Bauman, Norman // Urology Times;Oct2000, Vol. 28 Issue 10, p1 

    Reports on the results of a Phase I clinical trial of monoclonal antibodies for the treatment of metastatic prostate cancer. Process of metastatic binding; Antitumor responses to monoclonal antibodies of animal models; Mechanisms by which monoclonal antibodies are used in the treatment of...

  • Advances and Challenges in Diagnosis and Management of Skeletal Metastases. Papagelopoulos, Panayiotis J.; Savvidou, Olga D.; Galanis, Evanthia C.; Mavrogenis, Andreas F.; Jacofsky, David J.; Frassica, Frank J.; Sim, Franklin H. // Orthopedics;Jul2006, Vol. 29 Issue 7, p609 

    Presents a continuing medical education article on the pathophysiology of metastatic bone disease. Effect of bone metastases on destructive skeletal lesion; Treatment goals for patients with metastatic bone disease; Processes involved in metastatic bone disease; Approach used in evaluating...

  • The chick embryo chorioallantoic membrane as a model to study tumor metastasis. Cimpean, Anca Maria; Ribatti, Domenico; Raica, Marius // Angiogenesis;Dec2008, Vol. 11 Issue 4, p311 

    Tumor metastasis represents a major problem in the treatment of patients with different cancers. Specific phenotype and behavior of metastatic cells derive from specific molecular mechanisms involved in consecutive steps of the metastatic process. Several in vitro and in vivo experimental models...

  • Metastatic breast carcinoma of the coracoid process: two case reports. Benson, Eric C.; Drosdowech, Darren S. // Journal of Orthopaedic Surgery & Research;2010, Vol. 5, p22 

    Background: The coracoid process of the scapula is a rare site of involvement for metastatic disease or for primary tumors. We are unaware of any reports in the literature of pathologic coracoid process fractures and only one report of metastatic disease to the coracoid. Methods and Results: In...

  • Circulating tumour cells-a bona fide cause of metastatic cancer. Caixeiro, N.; Kienzle, N.; Lim, S.; Spring, K.; Tognela, A.; Scott, K.; Souza, P.; Becker, T. // Cancer & Metastasis Reviews;Sep2014, Vol. 33 Issue 2/3, p747 

    Circulating tumour cells (CTCs) are emerging as important prognostic markers and have potential clinical utility as tumour biomarkers for targeted cancer therapy. Although CTCs were proposed more than 100 years ago as potential precursors that may form metastatic lesions, formal evidence that...

  • A key to metastasis. Greenwood, Emma // Nature Reviews Cancer;Feb2004, Vol. 4 Issue 2, p94 

    The article focuses on a study showing ezrin is upregulated in metastatic cancers and is key to the metastatic process. A rhabdomyosarcoma mouse model is used to establish cell lines that were either highly or poorly metastatic when injected into mice. A microarray expression profiling was...

  • Changing views of the role of matrix metalloproteinases in metastasis. Chambers, Ann F.; Matrisian, Lynn M. // JNCI: Journal of the National Cancer Institute;09/03/97, Vol. 89 Issue 17, p1260 

    Re-examines the evidence that matrix metalloproteinases (MMPs) are linked with metastasis, the spread of cancer from a primary tumor to distant site of the body. Overview of the metastatic process; MMPs' functional contribution to the process; Molecular mechanisms of metastasis; MMPs as key...

  • What defines a useful marker of metastasis in human cancer? Welch, Danny R.; Rinker-Schaeffer, Carrie W.; Welch, D R; Rinker-Schaeffer, C W // JNCI: Journal of the National Cancer Institute;08/18/99, Vol. 91 Issue 16, p1351 

    Editorial. Presents information on metastasis, the lethal attribute of cancer. Distinction of metastatic process from tumorigenicity; Categories of markers; Advantages of identification of suppressors of metastasis.

  • Oncology and Pathology.  // Current Medical Literature: Ophthalmology;2007, Vol. 17 Issue 1, p38 

    The article presents abstracts of research related to oncology and pathology. They include "The patient's role in the decision-making process - a perspective from the Liverpool Ocular Oncology Centre," "Optic nerve invasion of uveal melanoma: clinical characteristics and metastatic pattern" and...

Share

Read the Article

Other Topics